(S (NP (JJ Clinical) (NN decision) (NN support) (NNS systems)) (VP (VBP have) (VP (VBN been) (VP (VBN developed) (S (VP (TO to) (VP (VB help) (NP (NNS physicians)) (S (VP (TO to) (VP (VB take) (NP (JJ clinical) (NNS guidelines)) (PP (IN into) (NP (NN account))) (PP (IN during) (NP (NNS consultations)))))))))))) (. .))
(S (S (NP (DT The) (NNP ASTI) (VBG critiquing) (NN module)) (VP (VBZ is) (NP (CD one) (JJ such) (NNS systems)))) (: ;) (S (NP (PRP it)) (VP (VBZ provides) (NP (DT the) (NN physician)) (PP (IN with) (NP (JJ automatic) (NNS criticisms))) (SBAR (WHADVP (WRB when)) (S (NP (DT a) (NN drug) (NN prescription)) (VP (VBZ does) (RB not) (VP (VB follow) (NP (DT the) (NNS guidelines)))))))) (. .))
(S (NP (PRP It)) (VP (VP (VBD was) (ADVP (RB initially)) (VP (VBN developed) (PP (IN for) (NP (NP (NN hypertension)) (CC and) (NP (NML (NN type) (CD 2)) (NN diabetes)))))) (, ,) (CC but) (VP (VBZ is) (VP (VBN designed) (S (VP (TO to) (VP (VB be) (ADJP (ADJP (JJ generic) (JJ enough)) (PP (IN for) (NP (NN application)))) (PP (IN to) (NP (DT all) (JJ chronic) (NNS diseases))))))))) (. .))
(S (S (NP (PRP We)) (VP (VBP present) (ADVP (RB here)) (NP (NP (DT the) (NNS results)) (PP (IN of) (NP (NP (NN usability) (CC and) (NN satisfaction) (NNS evaluations)) (PP (IN for) (NP (NP (DT the) (NNP ASTI) (VBG critiquing) (NN module)) (, ,) (VP (VBN obtained) (PP (IN with) (NP (NP (NNS GPs)) (PP (IN for) (NP (NP (DT a) (ADJP (RB newly) (VBN implemented)) (NN guideline)) (PP (VBG concerning) (NP (NN dyslipaemia))))))))))))))) (, ,) (CC and) (S (S (NP (PRP we)) (VP (VBP discuss) (SBAR (S (NP (DT the) (NNS lessons)) (VP (VBD learnt)))))) (CC and) (S (NP (DT the) (NNS difficulties)) (VP (VBD encountered) (SBAR (WHADVP (WRB when)) (S (VP (VBG building) (NP (DT a) (JJ generic) (NNP DSS)) (PP (IN for) (S (VP (VBG critiquing) (NP (NP (NNS physicians) (POS ')) (NNS prescriptions))))))))))) (. .))
